Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2017

01-03-2017 | Breast Oncology

Axillary Ultrasound Before Neoadjuvant Chemotherapy for Breast Cancer: Don’t Discount the Benefits Yet!

Authors: Theresa L. Schwartz, MD, FACS, Julie A. Margenthaler, MD, FACS

Published in: Annals of Surgical Oncology | Issue 3/2017

Login to get access

Excerpt

Axillary lymph node status remains a top prognostic indicator for patients with breast cancer. It has been well established that the extent of nodal involvement plays a key role in the risk for both local recurrence and overall survival, and nodal staging has a tremendous impact on systemic therapy and radiotherapy treatment recommendations. …
Literature
1.
go back to reference Krag D, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel lymph node resection compared with conventional axillary lymph node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.CrossRefPubMedPubMedCentral Krag D, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel lymph node resection compared with conventional axillary lymph node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.CrossRefPubMedPubMedCentral
2.
go back to reference Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.CrossRefPubMed Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.CrossRefPubMed
3.
go back to reference Tate JJ, Lewis V, Archer T, Guyer PG, Royle GT, Taylor I. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol. 1989;15:139–41.PubMed Tate JJ, Lewis V, Archer T, Guyer PG, Royle GT, Taylor I. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol. 1989;15:139–41.PubMed
4.
go back to reference Barrio AV, Mamtani A, Eaton A, et al. Is routine axillary imaging necessary in clinically node-negative patients undergoing neoadjuvant chemotherapy? Ann Surg Oncol. 2017. doi:10.1245/s10434-017-5765-y. Barrio AV, Mamtani A, Eaton A, et al. Is routine axillary imaging necessary in clinically node-negative patients undergoing neoadjuvant chemotherapy? Ann Surg Oncol. 2017. doi:10.​1245/​s10434-017-5765-y.
5.
go back to reference Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, Theriault RL, et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol. 2005;23:41–8.CrossRefPubMed Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, Theriault RL, et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol. 2005;23:41–8.CrossRefPubMed
6.
go back to reference Lips EH, Mulder L, deRonde JJ, Mandjes IA, Vincent A, Vrancken Peeters MT, et al. Neoadjuvant chemotherapy in ER + HER2—breast cancer: response prediction based on immunohistochemical and molecular characteristics. Breast Cancer Res Treat. 2012;131:827–36.CrossRefPubMed Lips EH, Mulder L, deRonde JJ, Mandjes IA, Vincent A, Vrancken Peeters MT, et al. Neoadjuvant chemotherapy in ER + HER2—breast cancer: response prediction based on immunohistochemical and molecular characteristics. Breast Cancer Res Treat. 2012;131:827–36.CrossRefPubMed
8.
go back to reference Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, et al. Identification and resection of clipped node decreases the false-negative rate in patients presenting with node-positive breast cancer (T0–T4, N1–N2) who receive neoadjuvant chemotherapy. Ann Surg. 2016;263:802–7.CrossRefPubMed Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, et al. Identification and resection of clipped node decreases the false-negative rate in patients presenting with node-positive breast cancer (T0–T4, N1–N2) who receive neoadjuvant chemotherapy. Ann Surg. 2016;263:802–7.CrossRefPubMed
9.
go back to reference Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel lymph node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicenter cohort study. Lancet Oncol. 2013;14:609–18.CrossRefPubMed Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel lymph node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicenter cohort study. Lancet Oncol. 2013;14:609–18.CrossRefPubMed
10.
go back to reference Boileau JF, Poirier B, Basik M, Holloway M, Gaboury I, Sideris L, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2014;33:258–64.CrossRefPubMed Boileau JF, Poirier B, Basik M, Holloway M, Gaboury I, Sideris L, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2014;33:258–64.CrossRefPubMed
11.
go back to reference Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Breast and Bowel Project Protocol B-27. J Clin Oncol. 2005;23:2694–702.CrossRefPubMed Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Breast and Bowel Project Protocol B-27. J Clin Oncol. 2005;23:2694–702.CrossRefPubMed
12.
go back to reference Valente SA, Levine GM, Silverstein MJ, Rayhanabad JA, Weng-Grumley JC, Ji L, et al. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Ann Surg Oncol. 2012;19:1825–30.CrossRefPubMed Valente SA, Levine GM, Silverstein MJ, Rayhanabad JA, Weng-Grumley JC, Ji L, et al. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Ann Surg Oncol. 2012;19:1825–30.CrossRefPubMed
13.
go back to reference Diepstraten SC, Sever AR, Buckens CF, Veldhuis WB, vanDalen T, van den Bosch MA, et al. Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2014;21:51–9.CrossRefPubMed Diepstraten SC, Sever AR, Buckens CF, Veldhuis WB, vanDalen T, van den Bosch MA, et al. Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2014;21:51–9.CrossRefPubMed
14.
go back to reference Mamtani A, Barrio AV, King TA, Van Zee KJ, Plitas G, Pilewskie M, et al. How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study. Ann Surg Oncol. 2016;23:3467–74.CrossRefPubMed Mamtani A, Barrio AV, King TA, Van Zee KJ, Plitas G, Pilewskie M, et al. How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study. Ann Surg Oncol. 2016;23:3467–74.CrossRefPubMed
15.
go back to reference Qiu SQ, Zeng HC, Zhang F, Chen C, Huang WH, Pleijhuis RG, et al. A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound. Sci Rep. 2016;6:21196.CrossRefPubMedPubMedCentral Qiu SQ, Zeng HC, Zhang F, Chen C, Huang WH, Pleijhuis RG, et al. A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound. Sci Rep. 2016;6:21196.CrossRefPubMedPubMedCentral
16.
go back to reference Gentilini O1, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: sentinel node vs observation after axillary UltraSouND). Breast. 2012;21:678–81. Gentilini O1, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: sentinel node vs observation after axillary UltraSouND). Breast. 2012;21:678–81.
Metadata
Title
Axillary Ultrasound Before Neoadjuvant Chemotherapy for Breast Cancer: Don’t Discount the Benefits Yet!
Authors
Theresa L. Schwartz, MD, FACS
Julie A. Margenthaler, MD, FACS
Publication date
01-03-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 3/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-5766-x

Other articles of this Issue 3/2017

Annals of Surgical Oncology 3/2017 Go to the issue